IMNM EBITDA Growth
Immunome Inc · EBITDA Growth
IMNM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-37.98%period ending
IMNM TTM EBITDA YoY % (-75.29% → -37.98%)
Year-over-year change
High-resolution chart · PNG
IMNM ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -37.9792% | |
| -28.7044% | |
| -38.3769% | |
| -77.6506% | |
| -156.5485% | |
| -298.0719% | |
| -454.5118% | |
| -417.9488% | |
| -178.317% | |
| -49.8268% | |
| 24.7346% | |
| 41.7928% | |
| 28.2215% | |
| 9.0479% | |
| -51.4449% | |
| -82.1396% | |
| -70.7329% | |
| -73.7194% | |
| -40.5034% | |
| -25.4904% | |
| -101.1519% | |
| -82.8114% | |
| -75.2854% |